Physician profile
Todd Dietrick
NPI 1619963444
$47,225.25
in general payments reported to CMS, 2019-2025
8 companies · $36K in 2025
The $36K reported for 2025 was more than what 86% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,889 · 2020: $145 · 2021: $2,420 · 2022: $127 · 2023: $843 · 2024: $3,358 · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $31K · Consulting Fee: $7,250 · Food and Beverage: $1,857 · Travel and Lodging: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $30,970.27 |
| Consulting Fee | $7,250.00 |
| Food and Beverage | $1,856.57 |
| Travel and Lodging | $568.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $41,781.53 | 2019-2025 | |
| Medical Device Business Services, INC. | $3,175.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,799.14 | 2019-2025 | Rosa, Persona, Mymobility Platform |
| Smith+Nephew, INC. | $276.84 | 2019-2025 | Coblation |
| Depuy Synthes Sales INC. | $166.61 | 2019-2025 | Orthovisc |
| Kci USA, INC. | $13.08 | 2019 | |
| Next Science LLC | $12.57 | 2023 | Surgx, Blastx, Xperience |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$78,198.69 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Dietrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.